Voyager Therapeutics Inc
VYGR
$2.71+2.46%
Delayed · as of Sep 30, 2026, 1:32 PM ET
Mkt cap
$225.37M
EV/Sales
3.96
P/E ratio
N/A
FY2025 Revenue
$40.37M
EPS (TTM)
$-1.81
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-296.53%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Voyager Therapeutics Inc (VYGR) is a biotechnology company listed on NASDAQ.
Latest reported VYGR revenue for 2025-12-31 was $40.4M. Net income was -$119.7M. Revenue was down 49.5% from 2024-12-31 to 2025-12-31. VYGR currently screens at market cap $225.4M.
Use this VYGR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full VYGR income, balance, and cash tables.
Voyager Therapeutics Inc (VYGR) is a biotechnology company in the Healthcare sector.
Latest cached Voyager Therapeutics Inc (VYGR) revenue for Dec 31, 2025 was $40.4M. Net income was -$119.7M. Statements: https://lician.com/financials/vygr
Voyager Therapeutics Inc (VYGR) market capitalization is $225.4M on the latest cached snapshot.
Voyager Therapeutics Inc (VYGR) cached previous close $2.64; day range $2.61 – $2.71; volume 260,978. Session quote: https://lician.com/quote/vygr
Voyager Therapeutics Inc (VYGR) latest cached earnings event is "VYGR earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached VYGR filing is 8-K · Jul 13, 2026. Filings: https://lician.com/sec/vygr